Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jean-Michel Dogné and François Mullier.
Jean-Michel Dogné
Connection Strength
3.448
François Mullier
  1. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica. 2021 08 12.
    View in: PubMed
    Score: 0.240
  2. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
    View in: PubMed
    Score: 0.236
  3. Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data. Data Brief. 2020 Dec; 33:106519.
    View in: PubMed
    Score: 0.228
  4. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2021 01; 197:20-23.
    View in: PubMed
    Score: 0.227
  5. [Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
    View in: PubMed
    Score: 0.226
  6. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020; 18:17.
    View in: PubMed
    Score: 0.225
  7. Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application. J Thromb Haemost. 2019 08; 17(8):1273-1287.
    View in: PubMed
    Score: 0.206
  8. Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study. Thromb J. 2018; 16:28.
    View in: PubMed
    Score: 0.199
  9. BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis? TH Open. 2018 Jan; 2(1):e68-e88.
    View in: PubMed
    Score: 0.189
  10. Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study. Thromb Res. 2017 Aug; 156:142-148.
    View in: PubMed
    Score: 0.180
  11. Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review. Molecules. 2017 Apr 11; 22(4).
    View in: PubMed
    Score: 0.178
  12. Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates. Blood Transfus. 2018 02; 16(2):163-172.
    View in: PubMed
    Score: 0.177
  13. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia. J Thromb Thrombolysis. 2017 Feb; 43(2):224-232.
    View in: PubMed
    Score: 0.176
  14. Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation. Nanobiomedicine (Rij). 2014 Jan-Dec; 1:4.
    View in: PubMed
    Score: 0.142
  15. Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
    View in: PubMed
    Score: 0.061
  16. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol. 2021; 12:708302.
    View in: PubMed
    Score: 0.060
  17. Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2. Microorganisms. 2021 Jun 21; 9(6).
    View in: PubMed
    Score: 0.060
  18. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7.
    View in: PubMed
    Score: 0.059
  19. Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents. Int J Lab Hematol. 2019 Jun; 41(3):316-324.
    View in: PubMed
    Score: 0.050
  20. Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma. Int J Lab Hematol. 2019 Apr; 41(2):250-261.
    View in: PubMed
    Score: 0.050
  21. Development and validation of a liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of serotonin and thromboxane B2 from activated platelets. Int J Lab Hematol. 2018 Dec; 40(6):663-671.
    View in: PubMed
    Score: 0.049
  22. Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide. Thromb Haemost. 2018 Jul; 118(7):1203-1214.
    View in: PubMed
    Score: 0.048
  23. Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. Expert Opin Biol Ther. 2017 10; 17(10):1275-1296.
    View in: PubMed
    Score: 0.045
  24. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants. Thromb Res. 2017 Sep; 157:29-37.
    View in: PubMed
    Score: 0.045
  25. Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels. Thromb Res. 2017 08; 156:36-38.
    View in: PubMed
    Score: 0.045
  26. Perioperative management of patients on direct oral anticoagulants. Thromb J. 2017; 15:14.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.